APP and Alzheimer disease: designed a microemulsion to deliver piperine to the CNS for the treatment of AD Frequency modulation in the production of the amyloid precursor protein, which decreases A generation, decreases secretase rates, and increases A degradation and transportation out from the brain would be the mechanism for anti-AD therapy.